ESG
Jul 29, 2026
Taipei, Taiwan and Seoul, South Korea, 29 July 2026 — Lotus Pharmaceutical Co., Ltd. (Taiwan Stock Exchange: 1795, “Lotus” or the “Company”), a global pharmaceutical company headquartered in Taiwan, today announced that ...
View our ESG events highlighting our efforts to support the community, patients, and the environment.
.jpg)
ESG
Jul 29, 2026
Taipei, Taiwan and Seoul, South Korea, 29 July 2026 — Lotus Pharmaceutical Co., Ltd. (Taiwan Stock Exchange: 1795, “Lotus” or the “Company”), a global pharmaceutical company headquartered in Taiwan, today announced that ...

ESG
Dec 29, 2025
Taipei, Taiwan, 29 December 2025 — Lotus Pharmaceuticals (1795:TT; “Lotus” or “the Company”), a multinational pharmaceutical company, today announce its sponsor for the Street Medicine Program operated by the Charitable ...

ESG
Nov 18, 2025
‘Hellow’ Volunteer Program Provides Tangible Support to Underprivileged Communities and Strengthens Local Engagement Alvogen Korea (CEO: Woo-se Lee) extended warmth to underprivileged members of the community through its annual Kimchi Sha...

ESG
Aug 15, 2025
Taipei, Taiwan, 15 August 2025 — Lotus Pharmaceutical Co., Ltd. (“Lotus”, TWSE Stock Code: 1795), a leading multinational pharmaceutical company, proudly announces its continued recognition as one of Asia’s most exemplary...

ESG
May 26, 2025
500 Loaves Prepared with Professional Bakers Delivered to Underprivileged Community Members Part of the Hellow CSR Campaign: “Fostering a Sustainable Culture of Giving” Alvogen Korea, the Korean branch of global pharmaceutical company Alv...

ESG
May 13, 2025
(May 13, 2025) – Alvogen Korea, a global healthcare company (CEO: Lee Jun-soo), celebrated Parents’ Day by hosting a meaningful talent-based volunteer activity at the Dimode Children’s Center (Director: Jeong Hye-seon) on May 12. Me...

